The Canadian Natural Health Products (NHP) Regulations were implemented on January 1, 2004. The NHP Regulations classify NHPs as a sub-category of drugs, and include products like vitamins, minerals, herbal preparations, and homeopathic medicines. The NHP Regulations specify industry standards for manufacturing, packaging, labeling, storing, importing, distributing, and the sale of NHPs in Canada. This classification and regulation of NHPs is unique internationally, and raises questions about how the industry will be able to comply. The thesis objectives are to explore the response of NHP industry members to the NHP Regulations, including their experiences and perceptions. Data were collected via qualitative interviews with presidents and/or quality assurance managers of Canadian NHP companies. The findings may be used by policy makers to facilitate industry compliance with new regulations. Furthermore, this study of firm compliance provides insight into how to study the implementation stage of policy processes.